Nilima Parry‐Jones

1.0k total citations
21 papers, 500 citations indexed

About

Nilima Parry‐Jones is a scholar working on Pathology and Forensic Medicine, Genetics and Oncology. According to data from OpenAlex, Nilima Parry‐Jones has authored 21 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pathology and Forensic Medicine, 14 papers in Genetics and 9 papers in Oncology. Recurrent topics in Nilima Parry‐Jones's work include Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Viral-associated cancers and disorders (8 papers). Nilima Parry‐Jones is often cited by papers focused on Lymphoma Diagnosis and Treatment (15 papers), Chronic Lymphocytic Leukemia Research (14 papers) and Viral-associated cancers and disorders (8 papers). Nilima Parry‐Jones collaborates with scholars based in United Kingdom, Australia and Italy. Nilima Parry‐Jones's co-authors include Daniel Catovsky, Estella Matutes, Andrew Wotherspoon, G. John Swansbury, B. Carritt, Hazel Welch, Alicja Gruszka, Bridget S. Wilkins, V Brito-Babapulle and Monica Else and has published in prestigious journals such as Blood, Transplantation and British Journal of Haematology.

In The Last Decade

Nilima Parry‐Jones

19 papers receiving 482 citations

Peers

Nilima Parry‐Jones
Daniel Jones United States
J.J. Sotto France
David H. Vesole United States
Jennifer Orchard United Kingdom
Daniel Jones United States
Nilima Parry‐Jones
Citations per year, relative to Nilima Parry‐Jones Nilima Parry‐Jones (= 1×) peers Daniel Jones

Countries citing papers authored by Nilima Parry‐Jones

Since Specialization
Citations

This map shows the geographic impact of Nilima Parry‐Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nilima Parry‐Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nilima Parry‐Jones more than expected).

Fields of papers citing papers by Nilima Parry‐Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nilima Parry‐Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nilima Parry‐Jones. The network helps show where Nilima Parry‐Jones may publish in the future.

Co-authorship network of co-authors of Nilima Parry‐Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Nilima Parry‐Jones. A scholar is included among the top collaborators of Nilima Parry‐Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nilima Parry‐Jones. Nilima Parry‐Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Walewska, Renata, Toby A. Eyre, Adrian Bloor, et al.. (2025). 2025 British Society for Haematology Guideline for the treatment of chronic lymphocytic leukaemia. British Journal of Haematology. 207(6). 2296–2313.
2.
Chaganti, Sridhar, Matthew R. Wilson, David Tucker, et al.. (2025). Clinical management of bispecific antibody therapy for lymphoma: A British Society for Haematology Good Practice Paper. British Journal of Haematology. 207(4). 1227–1241.
3.
Walewska, Renata, Toby A. Eyre, Sally F. Barrington, et al.. (2023). Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline. British Journal of Haematology. 204(1). 86–107. 8 indexed citations
4.
Walewska, Renata, Nilima Parry‐Jones, Toby A. Eyre, et al.. (2022). Guideline for the treatment of chronic lymphocytic leukaemia. British Journal of Haematology. 197(5). 544–557. 24 indexed citations
5.
Lip, Gregory Y.H., Terry McCormack, Alexander R. Lyon, et al.. (2021). Management of cardiovascular complications of bruton tyrosine kinase inhibitors. British Journal of Haematology. 196(1). 70–78. 15 indexed citations
6.
Parry‐Jones, Nilima, et al.. (2020). Guideline for diagnosis and management of hairy cell leukaemia (HCL) and hairy cell variant (HCL‐V). British Journal of Haematology. 191(5). 730–737. 17 indexed citations
7.
Parry‐Jones, Nilima, et al.. (2019). A relapse of POEMS syndrome presenting as acute kidney injury. BMJ Case Reports. 12(8). e228894–e228894. 1 indexed citations
8.
Schuh, Anna, Nilima Parry‐Jones, Niamh Appleby, et al.. (2018). Guideline for the treatment of chronic lymphocytic leukaemia. British Journal of Haematology. 182(3). 344–359. 17 indexed citations
9.
Hopkins, Emily, et al.. (2014). Subcutaneous seeding of ‘double hit’ diffuse large B-cell lymphoma from staging bone marrow biopsy. British Journal of Haematology. 166(5). 635–635. 3 indexed citations
10.
Jones, Gail, Nilima Parry‐Jones, Bridget S. Wilkins, Monica Else, & Daniel Catovsky. (2011). Revised guidelines for the diagnosis and management of hairy cell leukaemia and hairy cell leukaemia variant*. British Journal of Haematology. 156(2). 186–195. 54 indexed citations
11.
Parry‐Jones, Nilima, Estella Matutes, Ricardo Morilla, et al.. (2007). Cytogenetic abnormalities additional to t(11;14) correlate with clinical features in leukaemic presentation of mantle cell lymphoma, and may influence prognosis: a study of 60 cases by FISH. British Journal of Haematology. 137(2). 117–124. 33 indexed citations
12.
Giudice, Ilaria Del, Zadie Davis, Estella Matutes, et al.. (2006). IgVH genes mutation and usage, ZAP-70 and CD38 expression provide new insights on B-cell prolymphocytic leukemia (B-PLL). Leukemia. 20(7). 1231–1237. 23 indexed citations
13.
Huh, Yang O., Lynne V. Abruzzo, George Z. Rassidakis, et al.. (2006). The t(14;19)(q32;q13)‐positive small B‐cell leukaemia: a clinicopathologic and cytogenetic study of seven cases. British Journal of Haematology. 136(2). 220–228. 36 indexed citations
14.
Ruchlemer, Rosa, Nilima Parry‐Jones, Vasantha Brito‐Babapulle, et al.. (2004). B‐prolymphocytic leukaemia with t(11;14) revisited: a splenomegalic form of mantle cell lymphoma evolving with leukaemia. British Journal of Haematology. 125(3). 330–336. 43 indexed citations
15.
Matutes, Estella, Nilima Parry‐Jones, V Brito-Babapulle, et al.. (2004). The Leukemic Presentation of Mantle-cell Lymphoma: Disease Features and Prognostic Factors in 58 Patients. Leukemia & lymphoma. 45(10). 2007–2015. 40 indexed citations
16.
Giudice, Ilaria Del, Zadie Davis, Nnenna Osuji, et al.. (2004). B- Prolymphocytic Leukemia Shows Heterogeneous IgVH Mutational Status and Expression of ZAP-70 and CD38.. Blood. 104(11). 2004–2004. 2 indexed citations
17.
Parry‐Jones, Nilima, Estella Matutes, Alicja Gruszka, et al.. (2003). Prognostic features of splenic lymphoma with villous lymphocytes: a report on 129 patients. British Journal of Haematology. 120(5). 759–764. 91 indexed citations
18.
Parry‐Jones, Nilima, Martin Gore, Jordan E. Taylor, & J. Treleaven. (1999). Delayed haemolytic transfusion reaction caused by anti-M antibody in a patient receiving interleukin-2 and interferon for metastatic renal cell cancer. Clinical & Laboratory Haematology. 21(6). 407–408. 9 indexed citations
19.
Marsh, J. C. W., Joanna Chowdry, Nilima Parry‐Jones, et al.. (1999). Study of the association between cytochromes P450 2D6 and 2E1 genotypes and the risk of drug and chemical induced idiosyncratic aplastic anaemia. British Journal of Haematology. 104(2). 266–270. 21 indexed citations
20.
Parry‐Jones, Nilima, Tanzina Haque, Lydia Jones, et al.. (1999). EPSTEIN-BARR VIRUS (EBV) ASSOCIATED B-CELL LYMPHOPROLIFERATIVE DISEASE FOLLOWING HLA IDENTICAL SIBLING MARROW TRANSPLANTATION FOR APLASTIC ANAEMIA IN A PATIENT WITH AN EBV SERONEGATIVE DONOR. Transplantation. 67(10). 1373–1375. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026